These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36638768)

  • 41. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive outcomes in late-onset versus adult-onset Multiple Sclerosis.
    Oliveira AI; Monteiro IR; Alferes AR; Santos I; Machado R; Correia I; Macário C; Nunes CC; Batista S
    Mult Scler Relat Disord; 2024 Oct; 90():105845. PubMed ID: 39197350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
    D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
    Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry.
    Braune S; Bluemich S; Bruns C; Dirks P; Hoffmann J; Heer Y; Rouzic EM; Bergmann A;
    BMC Neurol; 2023 Jul; 23(1):258. PubMed ID: 37407914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.
    Lanzillo R; Moccia M; Palladino R; Signoriello E; Carotenuto A; Maniscalco GT; Saccà F; Bonavita S; Russo CV; Iodice R; Petruzzo M; Sinisi L; De Angelis M; Lavorgna L; De Rosa A; Romano F; Orlando V; Ronga B; Florio C; Lus G; Brescia Morra V
    Mult Scler Relat Disord; 2020 Feb; 38():101871. PubMed ID: 31786463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
    Qiu W; Wu JS; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Clin Neurosci; 2010 Aug; 17(8):1009-13. PubMed ID: 20580995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal imaging and axonal degeneration in later onset multiple sclerosis.
    Huhn K; Lämmer R; Zimmermann H; Lämmer A; Waschbisch A; Utz K; Gieß RM; Paul F; Linker RA; Lee DH
    J Neurol Sci; 2016 Nov; 370():1-6. PubMed ID: 27772735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demographic and clinical characterization of multiple sclerosis in Mexico: The REMEMBer study.
    Bertado-Cortés B; Venzor-Mendoza C; Rubio-Ordoñez D; Pérez-Pérez JR; Novelo-Manzano LA; Villamil-Osorio LV; Jiménez-Ortega MJ; Villalpando-Gueich ML; Sánchez-Rosales NA; García-Talavera V
    Mult Scler Relat Disord; 2020 Nov; 46():102575. PubMed ID: 33296973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term disability progression of pediatric-onset multiple sclerosis.
    McKay KA; Hillert J; Manouchehrinia A
    Neurology; 2019 Jun; 92(24):e2764-e2773. PubMed ID: 31092624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple sclerosis by phenotype in Germany.
    Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
    Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.
    Saeedi J; Rieckmann P; Yee I; Tremlett H;
    Mult Scler; 2012 Sep; 18(9):1239-43. PubMed ID: 22383230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability.
    Cerqueira Pinto SC; Ferreira Vasconcelos CC; Aurenção JCK; Alvarenga MP; das Graças Gomes Camargo SM; Santos Thuler LC; Alvarenga RP
    Pediatr Neurol; 2019 May; 94():48-54. PubMed ID: 30850228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating the efficacy and safety of Zytux
    Naser Moghadasi A; Darki A; Masoumi P; Hashemi SN; Ghadiri F
    Mult Scler Relat Disord; 2019 Nov; 36():101419. PubMed ID: 31586800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
    Foo EC; Russell M; Lily O; Ford HL
    Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Employment and absenteeism in working-age persons with multiple sclerosis.
    Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
    J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics, course and prognosis of spinal multiple sclerosis.
    Nociti V; Cianfoni A; Mirabella M; Caggiula M; Frisullo G; Patanella AK; Sancricca C; Angelucci F; Tonali PA; Batocchi AP
    Spinal Cord; 2005 Dec; 43(12):731-4. PubMed ID: 16010274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
    Etemadifar M; Nasr-Esfahani AH; Khodabandehlou R; Maghzi AH
    Arch Iran Med; 2007 Apr; 10(2):152-6. PubMed ID: 17367215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.